EducationHow a lab checks a vial
What Does ">99% Purity" Actually Mean?
Written by Julia Piccoli, PhD
Associate R&D Director, Kemin Industries LATAM · Published · 6 min read
">99% purity" usually means that the main peptide peak represents more than 99% of the total integrated peak area in a specific HPLC method. It does not mean that more than 99% of the powder's weight is peptide. Water, counter-ions, and other non-peptide components may still contribute to the total weight.

In this article+−
- What does a peptide purity percentage measure?
- What is usually in the remaining fraction?
- Can an impurity hide under the main peak?
- Why is HPLC purity different from net peptide content?
- How should the specification and result be read?
- What do "99.621%," "99.6%," and ">99%" mean?
- Frequently asked questions
- Sources
What does a peptide purity percentage measure?
When a peptide certificate of analysis reports ">99% purity," the number usually comes from high-performance liquid chromatography, or HPLC.
In reverse-phase HPLC, the sample's components travel through a column at different speeds, and the detector records each one as a peak on a chromatogram.
Purity is usually calculated from the main peak's area relative to the total integrated area of the peaks included:
Purity (%)=main peak area ÷ total integrated peak area× 100
On the example certificate, detection was performed at 214 nm. At this wavelength, the detector responds strongly to peptide bonds. The result is still a detector response under defined conditions. It is not a direct measurement of the powder's composition by weight.
The harmonized pharmacopeial chromatography chapter also explains that solvent, reagent, mobile-phase, and matrix peaks may be excluded, as may peaks at or below an established reporting threshold. This means that "total peak area" does not necessarily mean every signal visible in the chromatogram.
What is usually in the remaining fraction?
The remaining fraction often contains peptide-related impurities that are structurally similar to the target peptide.
These may include:
- Deletion sequences, in which an amino acid is missing
- Truncated sequences, in which the peptide chain stopped growing early
- Insertion sequences, which contain an additional amino acid
- Peptides with incompletely removed protecting groups
- Oxidized forms, particularly involving oxidation-sensitive residues
- Deamidated forms involving residues such as asparagine or glutamine
- Stereoisomers, including forms containing a D-amino acid instead of the expected L-amino acid
Some originate during synthesis; others may form later through chemical degradation.
In my experience, the phrase "the other 1%" needs to be treated carefully. It describes the separately detected and integrated signals, not necessarily every impurity present in the sample.
Can an impurity hide under the main peak?
Yes. An impurity can sometimes co-elute with the target peptide.
Co-elution occurs when two components leave the HPLC column at the same or a very similar time. The detector may then record them as one peak. If a related impurity is not chromatographically resolved from the target peptide, its response may be included in the area assigned to the main peak.
This is one of the details I examine when reviewing peptide chromatograms. A high main-peak area is valuable information, but it does not by itself demonstrate that the peak contains only one component.
Closely related impurities may need more than one analytical approach, such as a second chromatographic method or mass spectrometry alongside HPLC. HPLC shows how components separate under one set of conditions, while mass spectrometry provides mass information. Neither replaces the other.
A purity result is therefore method-specific. Its reliability depends not only on the detector but also on the column, mobile phase, gradient, wavelength, reporting threshold, and peak-integration approach.
Resolved impurity
Co-eluting impurity
Why is HPLC purity different from net peptide content?
This is the most important distinction when reading a peptide certificate.
HPLC purity asks:
What proportion of the integrated chromatographic signal is assigned to the main peptide peak?
Net peptide content asks:
How much of the material, by weight, is really the peptide?
Most synthetic peptides are isolated as salts. A charged peptide is associated with one or more counter-ions, such as acetate or trifluoroacetate. The counter-ion contributes to the weight of the powder, but it is not part of the peptide sequence.
The powder may also contain water retained after lyophilization and small amounts of residual solvent or other non-peptide material. These components are not represented in the HPLC area percentage in the same way as detectable peptide-related impurities.
So a peptide can have very high HPLC purity and a much lower peptide content by weight. There is no contradiction: the two numbers describe different properties.
The largest gap I have seen in the pharmaceutical industry was a peptide at about 99% HPLC purity with roughly 60% net peptide content, mostly because of counter-ions and residual water. Similar observations were reported by Ebbensgaard et al., and Stachurski et al. note that net peptide content typically ranges from 60% to 90%.
Two lots can have similar HPLC purity but different net peptide content because their water or counter-ion contributions differ.
Net peptide content may be established through approaches such as amino acid analysis, elemental analysis, quantitative nuclear magnetic resonance, or mass balance. The method and definition should be clear because different approaches do not always produce identical results.
RelatedWhy the salt form changes the weight
HPLC area result
- Main peak, about 99%
- Other integrated peaks
Powder by weight
- Peptide, about 60%
- Counter-ion
- Water
- Other non-peptide material
How should the specification and result be read?
A certificate of analysis normally presents both an acceptance criterion and the result measured for the batch.
The certificate reports:
Purity by HPLC at 214 nm
Reference standard>98%
Batch result99.621%
The measured result exceeds the stated criterion
Net content
Reference standard~10 mg
Batch result12.11 mg
The separately reported net-content result
Labeled quantity
Reference standard10 mg
Batch resultNot presented as a test result
The quantity stated for the sample
The 99.621% is the main peak's share of the integrated HPLC area under that method; the 12.11 mg is a separate net-content result. They are not two expressions of the same measurement.
When you review a peptide certificate, read purity together with net content, identity confirmation and the chromatogram, and check that the method is described well enough to understand how each result was obtained.
The example certificate identifies the method as reverse-phase HPLC using a C18 column and diode-array detection at 214 nm. It also reports identity confirmation by LC-MS.
RelatedHow to read a certificate of analysis
What do "99.621%," "99.6%," and ">99%" mean?
These do not make the same claim.
- 99.621% is the result reported by the analytical software.
- 99.6% is the same numerical result rounded to one decimal place.
- >99% is a threshold statement, not the exact measured result.
Both 99.01% and 99.99% meet a ">99%" threshold. The precise result should therefore be taken from the result column of the certificate.
The number of decimal places shown is not a measure of precision. Small changes in peak integration, wavelength, reporting threshold, or chromatographic resolution can affect the final decimal places. Two laboratories may therefore obtain somewhat different values if their methods do not separate and integrate the sample components in the same way.
Frequently Asked Questions
Is >99% purity the same as 99% peptide by weight?+−
No. HPLC purity is the main peak's share of the integrated detector response under a specific method. Net peptide content describes the amount of peptide present by weight. Counter-ions, water, and other non-peptide material can contribute to powder weight without reducing the HPLC area percentage in the same way as a resolved peptide impurity.
Why do peptides come with counter-ions?+−
Peptides with ionizable groups are commonly isolated as salts, with counter-ions balancing the peptide's charge. The type and amount depend on the peptide and its processing history. Counter-ions add weight to the material but are not part of the amino acid sequence, which is why they matter when interpreting net peptide content.
Can a peptide look pure by HPLC and still contain an impurity?+−
Yes. An impurity may be present below the reporting threshold, may respond differently at the chosen wavelength, or may co-elute with the main peptide. A high HPLC result is important, but it should be interpreted in the context of method performance, identity data, net peptide content, and the chromatogram.
What do I check first on a peptide certificate?+−
I start by checking whether identity, HPLC purity, net peptide content, and the chromatogram tell a consistent story. I then look at the method conditions, the minor peaks, and the possibility of co-elution. No single number provides a complete picture of peptide quality.
Sources
- Pharmacopoeial Discussion Group. Harmonized General Chapter G-20, Chromatography, corresponding to USP <621>. Normalization procedure, exclusions, and reporting thresholds. pmda.go.jp/files/000244598.pdf
- De Groot AS, Mattei A, Gabriel B, et al. Immunogenicity of generic peptide impurities: current orthogonal approaches. Pharmaceutical Research. 2025;42(5):805-818. doi.org/10.1007/s11095-025-03843-1
- Nugrahadi PP, Hinrichs WLJ, Frijlink HW, et al. Designing formulation strategies for enhanced stability of therapeutic peptides in aqueous solutions: a review. Pharmaceutics. 2023;15(3):935. doi.org/10.3390/pharmaceutics15030935
- McCarthy D, Han Y, Carrick K, et al. Reference standards to support quality of synthetic peptide therapeutics. Pharmaceutical Research. 2023;40(6):1317-1328. doi.org/10.1007/s11095-023-03493-1
- Kovera Labs Certificate of Analysis, report KVR-2026-BB7E5F. BPC-157, batch PP/BPC/062026. purepeptides.com/coa/bpc-157-pp-bpc-062026.pdf
- Ebbensgaard A, Mordhorst H, Overgaard MT, et al. Comparative evaluation of the antimicrobial activity of different antimicrobial peptides against a range of pathogenic bacteria. PLOS ONE 2015;10(12):e0144611 (methods: peptide purity and net peptide content) doi.org/10.1371/journal.pone.0144611
- Stachurski O, Neubauer D, Walewska A, et al. Understanding the role of self-assembly and interaction with biological membranes of short cationic lipopeptides in the effective design of new antibiotics. Antibiotics 2022;11(11):1491 doi.org/10.3390/antibiotics11111491
Worked example
The article borrows BPC-157 from the catalogue to show the idea on a real molecule.
The document in this article
BPC-157 certificate of analysisKovera Labs report KVR-2026-BB7E5F, batch PP/BPC/062026
Open the PDF
